JOURNEY STRATEGIC WEALTH LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1909316 SUMMIT, NJ

Position in UTHR

as of Mar 31, 2026 · filed Apr 15, 2026 Compact

Position Value

$608,394

+$76,319 QoQ

Shares Held

1,026

-6.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

7 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

JOURNEY STRATEGIC WEALTH LLC holds $1,715,451 across 5 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (35.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp This page	1,026	$608,394
2	ZTS	Zoetis Inc.	2,716	$321,055
3	NBIX	Neurocrine Biosciences Inc	2,355	$310,245
4	VTRS	Viatris Inc	17,761	$239,949
5	SUPN	Supernus Pharmaceuticals, Inc.	4,562	$235,808

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$608,394	1,026	-6.0%	Shares	Sole	2026-04-15
2025-12-31	$532,075	1,092	+14.6%	Shares	Sole	2026-02-13
2025-09-30	$399,504	953	+11.1%	Shares	Sole	2025-11-12
2025-06-30	$246,545	858	+32.8%	Shares	Sole	2025-08-12
2024-12-31	$227,932	646	+0.2%	Shares	Sole	2025-01-24
2024-09-30	$231,133	645	+2.5%	Shares	Sole	2024-11-12
2024-06-30	$200,367	629	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.